Skip to main content

Identification and Immunophenotypic Characterization of Normal and Pathological Mast Cells

  • Protocol
  • First Online:
Basophils and Mast Cells

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2163))

Abstract

Mast cells (MCs) are secretory cells that are central players in human allergic disease and immune responses. With the exception of a few pathological situations, MCs are usually present at relatively low frequencies in most tissues. Since their first description, MCs in tissues were identified mostly using their morphological characteristics and their typical coloration when stained with aniline dyes. However, increasing availability of highly specific antibodies now permits the use of fluorescence-based flow cytometry as the method of choice for the quantification, characterization, and purification of cells in suspension. This technique allows for a rapid analysis of thousands of events and for the identification of cells present at frequencies as low as one event in 106 unwanted cells. This method also permits for simultaneous characterization of multiple antigens at a single cell level, which is ideal in order to study rare populations of cells like MCs. Here we describe the basis of flow cytometry-based immunophenotyping applied to the study of MC. The protocol focuses on the study of human MCs present in body fluids (mainly bone marrow) but can easily be adapted to studying MCs from other tissues and species.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ishizuka T, Okajima F, Ishiwara M et al (2001) Sensitized mast cells migrate toward the antigen: a response regulated by p38 mitogen-activated protein kinase and Rho-associated coiled-coil-forming protein kinase. J Immunol 167:2298–2304

    Article  CAS  PubMed  Google Scholar 

  2. Kitaura J, Kinoshita T, Matsumoto M et al (2005) IgE- and IgE+Ag-mediated mast cell migration in an autocrine/paracrine fashion. Blood 105:3222–3229

    Article  CAS  PubMed  Google Scholar 

  3. Moon TC, St Laurent CD, Morris KE et al (2010) Advances in mast cell biology: new understanding of heterogeneity and function. Mucosal Immunol 3:111–128

    Article  CAS  PubMed  Google Scholar 

  4. Kitamura Y, Ito A (2005) Mast cell-committed progenitors. Proc Natl Acad Sci U S A 102:11129–11130

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Shimizu Y, Sakai K, Miura T et al (2002) Characterization of “adult-type” mast cells derived from human bone marrow CD34(+) cells cultured in the presence of stem cell factor and interleukin-6. Interleukin-4 is not required for constitutive expression of CD54, Fc epsilon RI alpha and chymase, and CD13 expression is reduced during differentiation. Clin Exp Allergy 32:872–880

    Article  CAS  PubMed  Google Scholar 

  6. Austen KF, Boyce JA (2001) Mast cell lineage development and phenotypic regulation. Leuk Res 25:511–518

    Article  CAS  PubMed  Google Scholar 

  7. Jamur MC, Oliver C (2011) Origin, maturation and recruitment of mast cell precursors. Front Biosci (Schol Ed) 3:1390–1406

    PubMed  Google Scholar 

  8. Gross HJ, Verwer B, Houck D, Recktenwald D (1993) Detection of rare cells at a frequency of one per million by flow cytometry. Cytometry 14:519–526

    Article  CAS  PubMed  Google Scholar 

  9. Gross HJ, Verwer B, Houck D et al (1995) Model study detecting breast cancer cells in peripheral blood mononuclear cells at frequencies as low as 10(−7). Proc Natl Acad Sci U S A 92:537–541

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Leary JF (1994) Strategies for rare cell detection and isolation. Methods Cell Biol 42(Pt B):331–358

    Article  PubMed  Google Scholar 

  11. Leary JF, Schmidt DF, Gram JG et al (1994) High-speed flow cytometric analysis and sorting of human fetal cells from maternal blood for molecular characterization. Ann N Y Acad Sci 731:138–141

    Article  CAS  PubMed  Google Scholar 

  12. Sánchez ML, Almeida J, Vidriales B et al (2002) Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation. Leukemia 16:1460–1469

    Article  PubMed  Google Scholar 

  13. Mayrhofer G, Gadd SJ, Spargo LD, Ashman LK (1987) Specificity of a mouse monoclonal antibody raised against acute myeloid leukaemia cells for mast cells in human mucosal and connective tissues. Immunol Cell Biol 65:241–250

    Article  PubMed  Google Scholar 

  14. Lerner NB, Nocka KH, Cole SR et al (1991) Monoclonal antibody YB5.B8 identifies the human c-kit protein product. Blood 77:1876–1883

    Article  CAS  PubMed  Google Scholar 

  15. Ashman LK, Cambareri AC, To, L.B et al (1991) Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow. Blood 78:30–37

    Article  CAS  PubMed  Google Scholar 

  16. Orfao A, Escribano L, Villarrubia J et al (1996) Flow cytometric analysis of mast cells from normal and pathological human bone marrow samples: identification and enumeration. Am J Pathol 149:1493–1499

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Escribano L, Orfao A, Díaz-Agustin B et al (1998) Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications. Blood 91:2731–2736

    Article  CAS  PubMed  Google Scholar 

  18. Núñez-López R, Escribano L, Schernthaner G-H et al (2003) Overexpression of complement receptors and related antigens on the surface of bone marrow mast cells in patients with systemic mastocytosis. Br J Haematol 120:257–265

    Article  PubMed  Google Scholar 

  19. Escribano L, Orfao A, Díaz-Agustín B et al (1998) Human bone marrow mast cells from indolent systemic mast cell disease constitutively express increased amounts of the CD63 protein on their surface. Cytometry 34:223–228

    Article  CAS  PubMed  Google Scholar 

  20. Díaz-Agustín B, Escribano L, Bravo P et al (1999) The CD69 early activation molecule is overexpressed in human bone marrow mast cells from adults with indolent systemic mast cell disease. Br J Haematol 106:400–405

    Article  PubMed  Google Scholar 

  21. Teodosio C, García-Montero AC, Jara-Acevedo M et al (2010) Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes. J Allergy Clin Immunol 125:719–726

    Article  CAS  PubMed  Google Scholar 

  22. Alvarez-Twose I, Matito A, Sanchez-Munoz L et al (2012) Contribution of highly sensitive diagnostic methods to the diagnosis of systemic mastocytosis in the absence of skin lesions. Allergy 67:1190–1191

    Article  CAS  PubMed  Google Scholar 

  23. Sánchez-Muñoz L, Morgado JMT, Alvarez-Twose I et al (2013) Flow cytometry criteria for systemic mastocytosis: bone marrow mast cell counts do not always count. Am J Clin Pathol 139:404–406

    Article  PubMed  Google Scholar 

  24. Schernthaner GH, Jordan JH, Ghannadan M et al (2001) Expression, epitope analysis, and functional role of the LFA-2 antigen detectable on neoplastic mast cells. Blood 98:3784–3792

    Article  CAS  PubMed  Google Scholar 

  25. Agis H, Willheim M, Sperr WR et al (1993) Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly-, CD14-, CD17-, colony-forming cell. J Immunol 151:4221–4227

    Article  CAS  PubMed  Google Scholar 

  26. Agis H, Füreder W, Bankl HC et al (1996) Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes. Immunology 87:535–543

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Rottem M, Okada T, Goff JP, Metcalfe DD (1994) Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/Fc epsilon RI− cell population. Blood 84:2489–2496

    Article  CAS  PubMed  Google Scholar 

  28. Kempuraj D, Saito H, Kaneko A et al (1999) Characterization of mast cell-committed progenitors present in human umbilical cord blood. Blood 93:3338–3346

    Article  CAS  PubMed  Google Scholar 

  29. Kirshenbaum AS, Goff JP, Semere T et al (1999) Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13). Blood 94:2333–2342

    Article  CAS  PubMed  Google Scholar 

  30. Matarraz S, López A, Barrena S et al (2008) The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors. Leukemia 22:1175–1183

    Article  CAS  PubMed  Google Scholar 

  31. Dahl C, Hoffmann HJ, Saito H, Schiøtz PO (2004) Human mast cells express receptors for IL-3, IL-5 and GM-CSF; a partial map of receptors on human mast cells cultured in vitro. Allergy 59:1087–1096

    Article  CAS  PubMed  Google Scholar 

  32. Schernthaner G-H, Hauswirth AW, Baghestanian M et al (2005) Detection of differentiation- and activation-linked cell surface antigens on cultured mast cell progenitors. Allergy 60:1248–1255

    Article  CAS  PubMed  Google Scholar 

  33. Tedla N, Lee C-W, Borges L et al (2008) Differential expression of leukocyte immunoglobulin-like receptors on cord-blood-derived human mast cell progenitors and mature mast cells. J Leukoc Biol 83:334–343

    Article  CAS  PubMed  Google Scholar 

  34. Yokoi H, Myers A, Matsumoto K et al (2006) Alteration and acquisition of Siglecs during in vitro maturation of CD34+ progenitors into human mast cells. Allergy 61:769–776

    Article  CAS  PubMed  Google Scholar 

  35. Shimizu Y, Suga T, Maeno T et al (2004) Detection of tryptase-, chymase+ cells in human CD34 bone marrow progenitors. Clin Exp Allergy 34:1719–1724

    Article  CAS  PubMed  Google Scholar 

  36. Escribano L, Orfao A, Villarrubia J et al (1998) Immunophenotypic characterization of human bone marrow mast cells. A flow cytometric study of normal and pathological bone marrow samples. Anal Cell Pathol 16:151–159

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Escribano L, Garcia-Montero AC, Núñez R, Orfao A (2006) Flow cytometric analysis of normal and neoplastic mast cells: role in diagnosis and follow-up of mast cell disease. Immunol Allergy Clin N Am 26:535–547

    Article  Google Scholar 

  38. Galli SJ, Nakae S, Tsai M (2005) Mast cells in the development of adaptive immune responses. Nat Immunol 6:135–142

    Article  CAS  PubMed  Google Scholar 

  39. Marshall JS (2004) Mast-cell responses to pathogens. Nat Rev Immunol 4:787–799

    Article  CAS  PubMed  Google Scholar 

  40. Abraham SN, St John AL (2010) Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol 10:440–452

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Valent P, Schernthaner GH, Sperr WR et al (2001) Variable expression of activation-linked surface antigens on human mast cells in health and disease. Immunol Rev 179:74–81

    Article  CAS  PubMed  Google Scholar 

  42. Furuno T, Teshima R, Kitani S et al (1996) Surface expression of CD63 antigen (AD1 antigen) in P815 mastocytoma cells by transfected IgE receptors. Biochem Biophys Res Commun 219:740–744

    Article  CAS  PubMed  Google Scholar 

  43. Bühring HJ, Simmons PJ, Pudney M et al (1999) The monoclonal antibody 97A6 defines a novel surface antigen expressed on human basophils and their multipotent and unipotent progenitors. Blood 94:2343–2356

    PubMed  Google Scholar 

  44. Ghannadan M, Baghestanian M, Wimazal F et al (1998) Phenotypic characterization of human skin mast cells by combined staining with toluidine blue and CD antibodies. J Invest Dermatol 111:689–695

    Article  CAS  PubMed  Google Scholar 

  45. Frandji P, Oskéritzian C, Cacaraci F et al (1993) Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma. J Immunol 151:6318–6328

    Article  CAS  PubMed  Google Scholar 

  46. Henz BM, Maurer M, Lippert U et al (2001) Mast cells as initiators of immunity and host defense. Exp Dermatol 10:1–10

    Article  CAS  PubMed  Google Scholar 

  47. Wong GH, Clark-Lewis I, McKimm-Breschkin JL, Schrader JW (1982) Interferon-gamma-like molecule induces Ia antigens on cultured mast cell progenitors. Proc Natl Acad Sci U S A 79:6989–6993

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Woolhiser MR, Okayama Y, Gilfillan AM, Metcalfe DD (2001) IgG-dependent activation of human mast cells following up-regulation of FcgammaRI by IFN-gamma. Eur J Immunol 31:3298–3307

    Article  CAS  PubMed  Google Scholar 

  49. Bodni RA, Sapia S, Galeano A, Kaminsky A (2003) Indolent systemic mast cell disease: immunophenotypic characterization of bone marrow mast cells by flow cytometry. J Eur Acad Dermatol Venereol 17:160–166

    Article  CAS  PubMed  Google Scholar 

  50. Escribano L, Orfao A, Villarrubia J et al (1995) Expression of lymphoid-associated antigens in mast cells: report of a case of systemic mast cell disease. Br J Haematol 91:941–943

    Article  CAS  PubMed  Google Scholar 

  51. Escribano L, Orfao A, Villarrubia J et al (1997) Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia. Cytometry 30:98–102

    Article  CAS  PubMed  Google Scholar 

  52. Escribano L, Díaz-Agustín B, Bravo P et al (1999) Immunophenotype of bone marrow mast cells in indolent systemic mast cell disease in adults. Leuk Lymphoma 35:227–235

    Article  CAS  PubMed  Google Scholar 

  53. Escribano L, Díaz-Agustín B, Bellas C et al (2001) Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis. Leuk Res 25:563–570

    Article  CAS  PubMed  Google Scholar 

  54. Escribano L, Díaz-Agustín B, Núñez R et al (2002) Abnormal expression of CD antigens in mastocytosis. Int Arch Allergy Immunol 127:127–132

    Article  CAS  PubMed  Google Scholar 

  55. Pardanani A, Kim Linger T, Reeder T et al (2004) Bone marrow mast cell immunophenotyping in adults with mast cell disease: a prospective study of 33 patients. Leuk Res 28:777–783

    Article  CAS  PubMed  Google Scholar 

  56. Escribano L, Diaz-Agustin B, López A et al (2004) Immunophenotypic analysis of mast cells in mastocytosis: when and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA). Cytometry B Clin Cytom 58:1–8

    Article  PubMed  Google Scholar 

  57. Akin C, Escribano L, Nuñez R et al (2004) Well-differentiated systemic mastocytosis: a new disease variant with mature mast cell phenotype and lack of codon 816 c-Kit mutations. J Allergy Clin Immunol 113:S327

    Article  Google Scholar 

  58. Akin C, Fumo G, Yavuz AS et al (2004) A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib. Blood 103:3222–3225

    Article  CAS  PubMed  Google Scholar 

  59. Alvarez-Twose I, González de Olano D, Sánchez-Muñoz L et al (2010) Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms. J Allergy Clin Immunol 125:1269–1278

    Article  CAS  PubMed  Google Scholar 

  60. Bonadonna P, Perbellini O, Passalacqua G et al (2009) Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels. J Allergy Clin Immunol 123:680–686

    Article  CAS  PubMed  Google Scholar 

  61. Escribano L, Alvarez-Twose I, Sánchez-Muñoz L et al (2009) Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients. J Allergy Clin Immunol 124:514–521

    Article  PubMed  Google Scholar 

  62. Lim K-H, Tefferi A, Lasho TL et al (2009) Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood 113:5727–5736

    Article  CAS  PubMed  Google Scholar 

  63. Valent P, Horny HP, Escribano L et al (2001) Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 25:603–625

    Article  CAS  PubMed  Google Scholar 

  64. Valent P, Akin C, Escribano L et al (2007) Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Investig 37:435–453

    Article  CAS  Google Scholar 

  65. Garcia-Montero AC, Jara-Acevedo M, Teodosio C et al (2006) KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. Blood 108:2366–2372

    Article  CAS  PubMed  Google Scholar 

  66. Escribano L, Ocqueteau M, Almeida J et al (1998) Expression of the c-kit (CD117) molecule in normal and malignant hematopoiesis. Leuk Lymphoma 30:459–466

    Article  CAS  PubMed  Google Scholar 

  67. Gane P, Pecquet C, Crespeau H et al (1995) Flow cytometric monitoring of allergen induced basophil activation. Cytometry 19:361–365

    Article  CAS  PubMed  Google Scholar 

  68. Valent P, Majdic O, Maurer D et al (1990) Further characterization of surface membrane structures expressed on human basophils and mast cells. Int Arch Allergy Appl Immunol 91:198–203

    Article  CAS  PubMed  Google Scholar 

  69. Valent P, Bettelheim P (1992) Cell surface structures on human basophils and mast cells: biochemical and functional characterization. Adv Immunol 52:333–423

    Article  CAS  PubMed  Google Scholar 

  70. Valent P, Cerny-Reiterer S, Herrmann H et al (2010) Phenotypic heterogeneity, novel diagnostic markers, and target expression profiles in normal and neoplastic human mast cells. Best Pract Res Clin Haematol 23:369–378

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Morgado, J.M., Sánchez-Muñoz, L., Teodósio, C., Mora, L.M.E. (2020). Identification and Immunophenotypic Characterization of Normal and Pathological Mast Cells. In: Gibbs, B.F., Falcone, F.H. (eds) Basophils and Mast Cells. Methods in Molecular Biology, vol 2163. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0696-4_27

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-0696-4_27

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-0695-7

  • Online ISBN: 978-1-0716-0696-4

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics